SC 13D
SC 13D Filing
- Company
- Tanke Biosciences Corp
- Filed
- February 24, 2011
- Accession Number
- 0001193805-11-000375
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →